CECIL MARK EPPLER,WILLIAM W. MUIR III,DAVID ROBERT HUSTEAD,THOMAS GERARD CULLEN,RAPHAEL JOHANNES GERHARDUS ZWIJNENBERG
申请号:
BRPI0815821
公开号:
BRPI0815821A2
申请日:
2008.08.26
申请国别(地区):
BR
年份:
2015
代理人:
摘要:
Provided herein are compositions, combinations, and methods comprising NMDA antagonists including, but not limited to, NMDA glutamate receptor antagonists such as [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1-(7)-en-2-yl)alkyl]phosphonic acid and derivatives thereof, which are effective in reducing the amount of anesthetic required to maintain anesthesia (i.e. to achieve an anesthetic-sparing effect).